Péter Kelemen1, Dávid Pukancsik2, Mihály Újhelyi3, Ákos Sávolt4, Eszter Kovács5, Gabriella Ivády6, István Kenessey7, Tibor Kovács8, Alexia Stamatiou9, Viktor Smanykó10, Zoltán Mátrai11. 1. Department of Breast and Sarcoma Surgery, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: dr.kelemenp@gmail.com. 2. Department of Breast and Sarcoma Surgery, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: d.pukancsik@gmail.com. 3. Department of Breast and Sarcoma Surgery, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: ujmisi@gmail.com. 4. Department of Breast and Sarcoma Surgery, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: drsavolt@hotmail.com. 5. Department of Radiological Diagnostics, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: koveszt5@gmail.com. 6. Department of Surgical and Molecular Pathology, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: iv.gabi@gmail.com. 7. National Cancer Registry, National Institute of Oncology, Ráth György Str. 7-9., 1122, Budapest, Hungary; 2(nd) Department of Pathology, Semmelweis University, Üllői Str. 93., 1091, Budapest, Hungary. Electronic address: steveken12@yahoo.com. 8. Department of Breast Surgery, Guy's and St Thomas' Hospitals NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, United Kingdom. Electronic address: tiborkovacsdr@yahoo.co.uk. 9. School of Medicine, Semmelweis University, Üllői Str. 26, 1085, Budapest, Hungary. Electronic address: alexiastamatiou@gmail.com. 10. Department of Radiotherapy, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: smanykov@yahoo.com. 11. Department of Breast and Sarcoma Surgery, National Institute of Oncology, Ráth György Str. 7-9, 1122, Budapest, Hungary. Electronic address: matraidoc@gmail.com.
Abstract
INTRODUCTION: Limited data is available from studies that directly compare oncoplastic breast surgery and conventional breast-conserving surgery (CBCS) procedures. The aim of this study was to compare three volume displacement oncoplastic breast-conserving surgery (OBCS) techniques to CBCS procedures, providing more evidence and facilitating the standardization of OBCS techniques. PATIENTS AND METHODS: A retrospective single-centre comparative study was performed between January 2010 and January 2017 involving 758 breast cancer patients. The endpoints for comparison were oncological safety, frequency of complications, initiation time of adjuvant therapy, aesthetic outcome, quality of life and operation time. To compare data, statistical analyses were performed. RESULTS: The mean follow-up time was 51 months for the OBCS group and 52 months for the CBCS group. The excised weight of the specimens was significantly larger in the OBCS group than in the CBCS group (90 g vs. 63 g). The overall complication rate (5.7% vs. 6.6%), the initiation time of adjuvant therapy (4.2 weeks vs. 4.1 weeks) and the local recurrence rate (2.0% vs. 3.7%) did not differ significantly. Scores for the aesthetic outcome were significantly higher in the OBCS group; however, required longer operation time. CONCLUSION: The investigated OBCS procedures allowed the removal of large volumes of breast tissue with improved cosmetic outcomes without delay in adjuvant therapies, maintaining the oncological safety. However, OBCS required longer operation time. Furthermore, the extended radicality of the OBCS could reduce the rate of re-excision and completion mastectomy, although it may result in the overtreatment of some breast cancer patients.
INTRODUCTION: Limited data is available from studies that directly compare oncoplastic breast surgery and conventional breast-conserving surgery (CBCS) procedures. The aim of this study was to compare three volume displacement oncoplastic breast-conserving surgery (OBCS) techniques to CBCS procedures, providing more evidence and facilitating the standardization of OBCS techniques. PATIENTS AND METHODS: A retrospective single-centre comparative study was performed between January 2010 and January 2017 involving 758 breast cancerpatients. The endpoints for comparison were oncological safety, frequency of complications, initiation time of adjuvant therapy, aesthetic outcome, quality of life and operation time. To compare data, statistical analyses were performed. RESULTS: The mean follow-up time was 51 months for the OBCS group and 52 months for the CBCS group. The excised weight of the specimens was significantly larger in the OBCS group than in the CBCS group (90 g vs. 63 g). The overall complication rate (5.7% vs. 6.6%), the initiation time of adjuvant therapy (4.2 weeks vs. 4.1 weeks) and the local recurrence rate (2.0% vs. 3.7%) did not differ significantly. Scores for the aesthetic outcome were significantly higher in the OBCS group; however, required longer operation time. CONCLUSION: The investigated OBCS procedures allowed the removal of large volumes of breast tissue with improved cosmetic outcomes without delay in adjuvant therapies, maintaining the oncological safety. However, OBCS required longer operation time. Furthermore, the extended radicality of the OBCS could reduce the rate of re-excision and completion mastectomy, although it may result in the overtreatment of some breast cancerpatients.
Authors: Zoltán Mátrai; Péter Kelemen; Csaba Kósa; Róbert Maráz; Attila Paszt; Gábor Pavlovics; Ákos Sávolt; Zsolt Simonka; Dezső Tóth; Miklós Kásler; Andrey Kaprin; Petr Krivorotko; Ferenc Vicko; Piotr Pluta; Agnieszka Kolacinska-Wow; Dawid Murawa; Jerzy Jankau; Slawomir Ciesla; Daniel Dyttert; Martin Sabol; Andrii Zhygulin; Artur Avetisyan; Alexander Bessonov; György Lázár Journal: Pathol Oncol Res Date: 2022-06-15 Impact factor: 2.874
Authors: Florian Fitzal; Michael Bolliger; Daniela Dunkler; Angelika Geroldinger; Luca Gambone; Jörg Heil; Fabian Riedel; Jana de Boniface; Camilla Andre; Zoltan Matrai; Dávid Pukancsik; Regis R Paulinelli; Valerijus Ostapenko; Arvydas Burneckis; Andrej Ostapenko; Edvin Ostapenko; Francesco Meani; Yves Harder; Marta Bonollo; Andrea S M Alberti; Christoph Tausch; Bärbel Papassotiropoulos; Ruth Helfgott; Dietmar Heck; Hans-Jörg Fehrer; Markus Acko; Peter Schrenk; Elisabeth K Trapp; Pristauz-Telsnigg Gunda; Paliczek Clara; Giacomo Montagna; Mathilde Ritter; Jens-Uwe Blohmer; Sander Steffen; Laszlo Romics; Elizabeth Morrow; Katharina Lorenz; Mathias Fehr; Walter Paul Weber Journal: Ann Surg Oncol Date: 2021-10-13 Impact factor: 5.344
Authors: Alice Lee; Richard M Kwasnicki; Hasaan Khan; Yasmin Grant; Abigail Chan; Angela E E Fanshawe; Daniel R Leff Journal: BJS Open Date: 2021-11-09
Authors: Idam de Oliveira-Junior; Igor de Araujo da Silva; Fabíola Cristina Brandini da Silva; Jonathas José da Silva; Almir José Sarri; Carlos Eduardo Paiva; René Aloisio da Costa Vieira Journal: Breast Care (Basel) Date: 2020-07-17 Impact factor: 2.268
Authors: E Heeg; M B Jensen; L R Hölmich; A Bodilsen; R A E M Tollenaar; A V Laenkholm; B V Offersen; B Ejlertsen; M A M Mureau; P M Christiansen Journal: Br J Surg Date: 2020-08-06 Impact factor: 6.939